The initial U.S. experience with the Tempo active fixation temporary pacing lead in structural heart interventions
dc.contributor.author | Nazif, Tamim M. | |
dc.contributor.author | Chen, Shmuel | |
dc.contributor.author | Codner, Pablo | |
dc.contributor.author | Grossman, Paul M. | |
dc.contributor.author | Menees, Daniel S. | |
dc.contributor.author | Sanchez, Carlos E. | |
dc.contributor.author | Yakubov, Steven J. | |
dc.contributor.author | White, Jonathan | |
dc.contributor.author | Kapadia, Samir | |
dc.contributor.author | Whisenant, Brian K. | |
dc.contributor.author | Forrest, John K. | |
dc.contributor.author | Krishnaswamy, Amar | |
dc.contributor.author | Arshi, Arash | |
dc.contributor.author | Orford, James L. | |
dc.contributor.author | Leon, Martin B. | |
dc.contributor.author | Dizon, Jos� M. | |
dc.contributor.author | Kodali, Susheel K. | |
dc.contributor.author | Chetcuti, Stanley J. | |
dc.date.accessioned | 2020-05-05T19:35:51Z | |
dc.date.available | WITHHELD_12_MONTHS | |
dc.date.available | 2020-05-05T19:35:51Z | |
dc.date.issued | 2020-04-01 | |
dc.identifier.citation | Nazif, Tamim M.; Chen, Shmuel; Codner, Pablo; Grossman, Paul M.; Menees, Daniel S.; Sanchez, Carlos E.; Yakubov, Steven J.; White, Jonathan; Kapadia, Samir; Whisenant, Brian K.; Forrest, John K.; Krishnaswamy, Amar; Arshi, Arash; Orford, James L.; Leon, Martin B.; Dizon, Jos� M. ; Kodali, Susheel K.; Chetcuti, Stanley J. (2020). "The initial U.S. experience with the Tempo active fixation temporary pacing lead in structural heart interventions." Catheterization and Cardiovascular Interventions 95(5): 1051-1056. | |
dc.identifier.issn | 1522-1946 | |
dc.identifier.issn | 1522-726X | |
dc.identifier.uri | https://hdl.handle.net/2027.42/154941 | |
dc.description.abstract | ObjectivesThis multicenter retrospective study of the initial U.S. experience evaluated the safety and efficacy of temporary cardiac pacing with the Tempo® Temporary Pacing Lead.BackgroundDespite increasing use of temporary cardiac pacing with the rapid growth of structural heart procedures, temporary pacing leads have not significantly improved. The Tempo lead is a new temporary pacing lead with a soft tip intended to minimize the risk of perforation and a novel active fixation mechanism designed to enhance lead stability.MethodsData from 269 consecutive structural heart procedures were collected. Outcomes included device safety (absence of clinically significant cardiac perforation, new pericardial effusion, or sustained ventricular arrhythmia) and efficacy (clinically acceptable pacing thresholds with successful pace capture throughout the index procedure). Postprocedure practices and sustained lead performance were also analyzed.ResultsThe Tempo lead was successfully positioned in the right ventricle and achieved pacing in 264 of 269 patients (98.1%). Two patients (0.8%) experienced loss of pace capture. Procedural mean pace capture threshold (PCT) was 0.7 ± 0.8 mA. There were no clinically significant perforations, pericardial effusions, or sustained device‐related arrhythmias. The Tempo lead was left in place postprocedure in 189 patients (71.6%) for mean duration of 43.3 ± 0.7 hr (range 2.5–221.3 hr) with final PCT of 0.84 ± 1.04 mA (n = 80). Of these patients, 84.1% mobilized out of bed with no lead dislodgment.ConclusionThe Tempo lead is safe and effective for temporary cardiac pacing for structural heart procedures, provides stable peri and postprocedural pacing and allows mobilization of patients who require temporary pacing leads. | |
dc.publisher | John Wiley & Sons, Inc. | |
dc.subject.other | balloon valvuloplasty | |
dc.subject.other | transcatheter aortic valve replacement | |
dc.subject.other | temporary pacing | |
dc.subject.other | tamponade | |
dc.subject.other | pacemaker | |
dc.subject.other | electrophysiology | |
dc.title | The initial U.S. experience with the Tempo active fixation temporary pacing lead in structural heart interventions | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Medicine (General) | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/154941/1/ccd28476.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/154941/2/ccd28476_am.pdf | |
dc.identifier.doi | 10.1002/ccd.28476 | |
dc.identifier.source | Catheterization and Cardiovascular Interventions | |
dc.identifier.citedreference | Webb JG, Pasupati S, Achtem L, Thompson CR. Rapid pacing to facilitate transcatheter prosthetic heart valve implantation. Catheter Cardiovasc Interv. 2006; 68: 199 ‐ 204. | |
dc.identifier.citedreference | Siontis GC, Juni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR. A Meta‐Anal J Am Coll Cardiol. 2014; 64: 129 ‐ 140. | |
dc.identifier.citedreference | Auffret V, Puri R, Urena M, et al. Conduction disturbances after transcatheter aortic valve replacement: current status and future perspectives. Circulation. 2017; 136: 1049 ‐ 1069. | |
dc.identifier.citedreference | Hunter A, Johnson L, Coustasse A. Reduction of intensive care unit length of stay: the case of early mobilization. Health Care Manag (Frederick). 2014; 33: 128 ‐ 135. | |
dc.identifier.citedreference | Leong D, Sovari AA, Ehdaie A, et al. Permanent‐temporary pacemakers in the management of patients with conduction abnormalities after transcatheter aortic valve replacement. J Interv Card Electrophysiol. 2018; 52: 111 ‐ 116. | |
dc.identifier.citedreference | Chauhan A, Grace AA, Newell SA, et al. Early complications after dual chamber versus single chamber pacemaker implantation. Pacing Clin Electrophysiol. 1994; 17: 2012 ‐ 2015. | |
dc.identifier.citedreference | de Cock CC, Van Campen CM, In’t Veld JA, Visser CA. Utility and safety of prolonged temporary transvenous pacing using an active‐fixation lead: comparison with a conventional lead. Pacing Clin Electrophysiol. 2003; 26: 1245 ‐ 1248. | |
dc.identifier.citedreference | Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid‐term follow‐up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006; 47: 1214 ‐ 1223. | |
dc.identifier.citedreference | El Masry H, Breall JA. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Curr Cardiol Rev 2008; 4: 193 – 197. | |
dc.identifier.citedreference | Piazza N, Onuma Y, Jesserun E, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv. 2008; 1: 310 ‐ 316. | |
dc.identifier.citedreference | Grube E, Buellesfeld L, Mueller R, et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv. 2008; 1: 167 ‐ 175. | |
dc.identifier.citedreference | Bosmans JM, Kefer J, De Bruyne B, et al. Procedural, 30‐day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg. 2011; 12: 762 ‐ 767. | |
dc.identifier.citedreference | Murphy JJ. Current practice and complications of temporary transvenous cardiac pacing. BMJ. 1996; 312: 1134. | |
dc.identifier.citedreference | Jorgensen TH, De Backer O, Gerds TA, Bieliauskas G, Svendsen JH, Sondergaard L. Immediate post‐procedural 12‐Lead electrocardiography as predictor of late conduction defects after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018; 11: 1509 ‐ 1518. | |
dc.identifier.citedreference | Mangieri A, Lanzillo G, Bertoldi L, et al. Predictors of advanced conduction disturbances requiring a late (>/=48 H) permanent pacemaker following transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018; 11: 1519 ‐ 1526. | |
dc.identifier.citedreference | Tay EL, Gurvitch R, Wijeysinghe N, et al. Outcome of patients after transcatheter aortic valve embolization. JACC Cardiovasc Interv. 2011; 4: 228 ‐ 234. | |
dc.identifier.citedreference | Ibebuogu UN, Giri S, Bolorunduro O, et al. Review of reported causes of device embolization following trans‐catheter aortic valve implantation. Am J Cardiol. 2015; 115: 1767 ‐ 1772. | |
dc.identifier.citedreference | Fadahunsi OO, Olowoyeye A, Ukaigwe A, et al. Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: Analysis from the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry. JACC Cardiovasc Interv. 2016; 9: 2189 ‐ 2199. | |
dc.identifier.citedreference | Mauri V, Reimann A, Stern D, et al. Predictors of permanent pacemaker implantation after transcatheter aortic valve replacement with the SAPIEN 3. JACC Cardiovasc Interv. 2016; 9: 2200 ‐ 2209. | |
dc.identifier.citedreference | Webster M, Pasupati S, Lever N, Stiles M. Safety and feasibility of a novel active fixation temporary pacing Lead. J Invasive Cardiol. 2018; 30: 163 ‐ 167. | |
dc.identifier.citedreference | Lumia FJ, Rios JC. Temporary transvenous pacemaker therapy: an analysis of complications. Chest. 1973; 64: 604 ‐ 608. | |
dc.identifier.citedreference | Gammage MD. Temporary cardiac pacing. Heart. 2000; 83: 715 ‐ 720. | |
dc.identifier.citedreference | Austin JL, Preis LK, Crampton RS, Beller GA, Martin RP. Analysis of pacemaker malfunction and complications of temporary pacing in the coronary care unit. Am J Cardiol. 1982; 49: 301 ‐ 306. | |
dc.identifier.citedreference | Jowett NI, Thompson DR, Pohl JE. Temporary transvenous cardiac pacing: 6 years experience in one coronary care unit. Postgrad Med J. 1989; 65: 211 ‐ 215. | |
dc.identifier.citedreference | Betts TR. Regional survey of temporary transvenous pacing procedures and complications. Postgrad Med J. 2003; 79: 463 ‐ 465. | |
dc.identifier.citedreference | Lopez Ayerbe J, Villuendas Sabate R, Garcia Garcia C, et al. Temporary pacemakers: current use and complications. Rev Esp Cardiol. 2004; 57: 1045 ‐ 1052. | |
dc.identifier.citedreference | Metkus TS, Schulman SP, Marine JE, Eid SM. Complications and outcomes of temporary transvenous pacing: an analysis of >360,000 patients from the National Inpatient Sample. Chest. 2019; 155: 749 ‐ 757. | |
dc.identifier.citedreference | Fitzgerald P, Kusumoto F. The effects of septal myectomy and alcohol septal ablation for hypertrophic cardiomyopathy on the cardiac conduction system. J Interv Card Electrophysiol. 2018; 52: 403 ‐ 408. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.